RESEARCH

DDHP: Compounds Active Against Cancer Cell Lines from Priority Bioactive Extracts; Funding Agency: Philippine Council for Health Research and Development (PCHRD) Phase 2; 25 November 2021 – 24 May 2024

DDHP: Anti-inflammatory and Anti-pain Bioactive Hits from Priority Bioactive Extracts; Funding Agency: Philippine Council for Health Research and Development (PCHRD) Phase 4; 15 May 2021 – 14 May 2024

DDHP: Compounds Active Against Cancer Cell Lines from Priority Bioactive Extracts; Funding Agency: Philippine Council for Health Research and Development (PCHRD) Phase 1;1 October 2019 – 15 November 2021

DDHP: Anti-inflammatory and Anti-pain Bioactive Hits from Priority Bioactive Extracts; Funding Agency: Philippine Council for Health Research and Development (PCHRD) Phase 3; 1 February 2018 – 1 February 2021

Cyclooxygenase Inhibiting Activity of Chalcones Isolated from Syzygium samarangense (Blume) Merr. and their Aurone Derivatives; Funding Agency: OVCRD, UP Diliman; 1 August 2017 – 31 July 2018

DDHP: In Vitro Bioactivities and Toxicities of Bioactive Extracts, Bioactive Hits, Drug Candidates and Dosage Forms (as Project Staff); Funding Agency: Philippine Council for Health Research and Development (PCHRD);1 February 2017 – 31 January 2019

Cholinesterase Inhibitor/s from Moringa oleifera Lam Leaves; Funding Agency: Philippine Institute of Traditional and Alternative Health Care (PITAHC) through PCHRD; 28 October 2015 – 17 October 2016; 16 March 2017 – 15 June 2018

DDHP: Anti-inflammatory and Anti-Pain Agent/s from Terrestrial Organisms (Phase 2); Funding Agency: Philippine Council for Health Research and Development (PCHRD); November 2015 – January 2018

TERRAPHARMA: Chemical Standardization of Moringa oleifera Lam by Chromatographic Fingerprinting and Bioactive Compounds Analysis (Project Staff); Funding Agency: PhilippineCouncil for Health Research and Development (PCHRD); 1 July 2017 – 31 August 2018

DDHP: Anti-infective Agents from Endophytic and Epiphytic Fungi – Year 2 (Project Staff); Funding Agency: Philippine Council for Health Research and Development (PCHRD); November 2015 – October 2018

DDHP: Isolation and Structure Elucidation of Bioactive Components from Herbal Extracts from Benguet for Antidiabetes (Project Staff); Funding Agency: Philippine Council for Health Research and Development (PCHRD); January 2016 – December 2018

DDHP: Anti-inflammatory and Anti-Pain Agent/s from Terrestrial Organisms (Phase 1); Funding Agency: Philippine Council for Health Research and Development (PCHRD); September 2014 – August 2017

Anti-inflammatory and Anti-Pain Agent/s from Terrestrial Organisms; Funding Agency: Philippine Council for Health Research and Development (PCHRD); September 2014 – August 2016

Cholinesterase Inhibitory Activity of Philippine Plant Extracts for Neurodegenerative Disorders; Funding Agency: UP System under the Creative Work/Research Grant; April 2014 – March 2015

Carmona retusa preparations as anti-colic (Mutagenicity component); Funding Agency: Philippine Institute of Traditional and Alternative Health Care (PITAHC) ; 16 January 2014 – 15 January 2015

Comparison of the Antiurolithiatic Activity of Metabolized and Unmetabolized Blumea balsamifera (Sambong); Funding Agency: Office of the Vice-Chancellor for Research and Development (OVCRD), UP Diliman, QC; 15 December 2013 – 30 June 2015

Cholinesterase Inhibitor/s from Moringa oleifera Lam Leaves; Funding Agency: Natural Sciences Research Institute; January 2013 – December 2014

Herbal Extracts from Benguet for Bioactivity and ADMETox Assays; Funding Agency: Philippine Council for Health Research and Development (PCHRD); September 2013 – August 2015

Anti-inflammatory compounds from Moringa oleifera Lam. Leaves ; Funding Agency: Philippine Council for Health Research and Development; January 2012 – March 2015

Bioassay Guided Isolation of Hypoglycemic Compounds from Philippine Medicinal Plants using Novel Biosensors for Multiple Metabolites; Funding Agency: FIRCA, NIH, USA (UMBC Subaward Number 0000007997); 22 February 2010 – 30 November 2014

Cholinesterase Inhibitor/s from Quisqualis indica L. Leaves; Funding Agency: Natural Sciences Research Institute; January 2012 – December 2013; Mutagenicity and Clastogenicity Potential of Ulasimang Bato; Funding Agency: Philippine Institute of Traditional and Alternative Health Care (PITAHC) ; September 2012 – August 2013

Alpha Glucosidase Inhibitory Compounds from Terminalia catappa Leaves; Funding Agency: Natural Sciences Research Institute; April 2010 – June 2012

Chemical Transformation of the Methanol Extract of Kyllinga monocephala and its Characterization; Funding Agency: UP System ; February 2009 – August 2010

Mutagenicity and Clastogenicity Potential of Drug Preparations from Philippine Medicinal Plants; Funding Agency: Philippine Council for Health Research and Development (PCHRD); January 2007 – April 2010 Principle(s) from a Philippine Medicinal Plant.

NIRPROMP: Mutagenicity and Clastogenicity Potential of Drug Preparations from Philippine Medicinal Plants; January 2006 - December 2006, January 2007 - December 2007, January 2008 - April 2010

Isolation and Structure Elucidation of the Analgesic Constituent(s) of Kyllinga monocephala; January 2006 - December 2007

NIRPROMP: Mutagenicity and Clastogenicity Potential of Drug Preparations from Philippine Medicinal Plants; January 2006 - December 2006

Isolation and Structure Elucidation of the Analgesic Principle(s) from Dioscorea hispida (Dennst.); June 2005 - December 2006